Trokendi (topiramate recalls
The FDA has published 2 recalls involving Trokendi (topiramate since 2016. The latest was reported on 2 Jun 2021. Most were for potency & assay. Cardinal Health has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why trokendi (topiramate is recalled
Companies
By year
All trokendi (topiramate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Trokendi XR (topiramate) extended-release capsules 100 mg recalled | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Trokendi XR (topiramate) extended-release capsule, 50mg recalled | Supernus Pharmaceuticals | Potency & Assay | Nationwide |
Should you stop taking Trokendi (topiramate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.